Generally these were cross-sectional analyses assessing total circulating osteocalcin which have associated lower osteocalcin concentrations with higher risk of Type 2 diabetes [35,36,37], higher body mass index (BMI) and plasma glucose concentrations [37,38], lower insulin sensitivity [39,40]. This evidence concerns the gene BGLAP and type 2 diabetes mellitus.